BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30531144)

  • 1. [Primary immunodeficiencies and hematological malignancies].
    Kanegane H; Hoshino A; Takagi M
    Rinsho Ketsueki; 2018; 59(11):2459-2467. PubMed ID: 30531144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary Immune Deficiency and Primary Immune Deficiency Crossovers: Hematological Malignancies and Autoimmune Diseases.
    Ballow M; Sánchez-Ramón S; Walter JE
    Front Immunol; 2022; 13():928062. PubMed ID: 35924244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematological Malignancies Associated With Primary Immunodeficiency Disorders.
    Duan L; Grunebaum E
    Clin Immunol; 2018 Sep; 194():46-59. PubMed ID: 29966714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary immunodeficiency and autoimmunity: A comprehensive review.
    Amaya-Uribe L; Rojas M; Azizi G; Anaya JM; Gershwin ME
    J Autoimmun; 2019 May; 99():52-72. PubMed ID: 30795880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary immunodeficiencies and haemato-oncology].
    Müller J; Kovács G
    Orv Hetil; 2018 Dec; 159(49):2073-2078. PubMed ID: 30525881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report of the Tunisian Registry of Primary Immunodeficiencies: 25-Years of Experience (1988-2012).
    Mellouli F; Mustapha IB; Khaled MB; Besbes H; Ouederni M; Mekki N; Ali MB; Larguèche B; Hachicha M; Sfar T; Gueddiche N; Barsaoui S; Sammoud A; Boussetta K; Becher SB; Meherzi A; Guandoura N; Boughammoura L; Harbi A; Amri F; Bayoudh F; Jaballah NB; Tebib N; Bouaziz A; Mahfoudh A; Aloulou H; Mansour LB; Chabchoub I; Boussoffara R; Chemli J; Bouguila J; Hassayoun S; Hammami S; Habboul Z; Hamzaoui A; Ammar J; Barbouche MR; Bejaoui M
    J Clin Immunol; 2015 Nov; 35(8):745-53. PubMed ID: 26464197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genes at the Crossroad of Primary Immunodeficiencies and Cancer.
    Derpoorter C; Bordon V; Laureys G; Haerynck F; Lammens T
    Front Immunol; 2018; 9():2544. PubMed ID: 30443258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The forefront of primary immunodeficiencies].
    Hoshino A
    Rinsho Ketsueki; 2018; 59(10):2195-2203. PubMed ID: 30305526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update in Primary Immunodeficiencies.
    Leonardi L; Rivalta B; Cancrini C; Chiappini E; Cravidi C; Caffarelli C; Manti S; Calvani M; Martelli A; Miraglia Del Giudice M; Duse M; Marseglia GL; Cardinale F
    Acta Biomed; 2020 Sep; 91(11-S):e2020010. PubMed ID: 33004780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic and extrinsic causes of malignancies in patients with primary immunodeficiency disorders.
    Hauck F; Voss R; Urban C; Seidel MG
    J Allergy Clin Immunol; 2018 Jan; 141(1):59-68.e4. PubMed ID: 28669558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and molecular mechanisms of immune dysregulation and autoimmunity.
    Azizi G; Pouyani MR; Abolhassani H; Sharifi L; Dizaji MZ; Mohammadi J; Mirshafiey A; Aghamohammadi A
    Cell Immunol; 2016 Dec; 310():14-26. PubMed ID: 27614846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary immunodeficiency and autoimmune diseases].
    Műzes G; Sipos F
    Orv Hetil; 2018 Jun; 159(23):908-918. PubMed ID: 29860882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary immunodeficiency disease and hematology].
    Kanegane H
    Rinsho Ketsueki; 2016; 57(10):2275-2284. PubMed ID: 27795540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risk of hematologic malignancies in primary immunodeficiency disorders: opportunities for immunotherapy.
    Verhoeven D; Stoppelenburg AJ; Meyer-Wentrup F; Boes M
    Clin Immunol; 2018 May; 190():22-31. PubMed ID: 29499421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monogenic polyautoimmunity in primary immunodeficiency diseases.
    Azizi G; Yazdani R; Rae W; Abolhassani H; Rojas M; Aghamohammadi A; Anaya JM
    Autoimmun Rev; 2018 Oct; 17(10):1028-1039. PubMed ID: 30107266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of Immune Dysregulation in Primary Immunodeficiencies: A Systematic Review.
    Mauracher AA; Gujer E; Bachmann LM; Güsewell S; Pachlopnik Schmid J
    J Allergy Clin Immunol Pract; 2021 Feb; 9(2):792-802.e10. PubMed ID: 33186766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignancies and Lymphoproliferations in Children With Primary Immune Deficiency-A Single-center Experience.
    Aydogmus C; Turkyilmaz Ucar O; Kaplan Sarikavak S; Cipe F; Ulas S; Turan I; Naiboglu S; Yildirim I; Kalay G; Kapci N; Al S; Gokmirza Ozdemir P; Celiksoy MH
    J Pediatr Hematol Oncol; 2024 Mar; 46(2):e169-e173. PubMed ID: 38277623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism-Based Strategies for the Management of Autoimmunity and Immune Dysregulation in Primary Immunodeficiencies.
    Walter JE; Farmer JR; Foldvari Z; Torgerson TR; Cooper MA
    J Allergy Clin Immunol Pract; 2016; 4(6):1089-1100. PubMed ID: 27836058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune Disease in Primary Immunodeficiency: At the Crossroads of Anti-Infective Immunity and Self-Tolerance.
    Saifi M; Wysocki CA
    Immunol Allergy Clin North Am; 2015 Nov; 35(4):731-52. PubMed ID: 26454316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Classification of Primary Immunodeficiencies of T Lymphocytes.
    Comrie WA; Lenardo MJ
    Adv Immunol; 2018; 138():99-193. PubMed ID: 29731008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.